Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 98

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 98
---
 NewGenIvf’s effective tax rate or tax liability may have an adverse effect on its results of operations.

NewGenIvf’s effective
tax rate could increase due to several factors, including, but not limited to:

| ● | changes in the relative                                                                                                          
 amounts of income before taxes in the various jurisdictions in which NewGenIvf operates that have differing statutory tax rates; |

| ● | changes in tax laws, tax                                 
 treaties, and regulations or the interpretation of them; |

| ● | changes to its assessment                                                                                                            
 about its ability to realize its deferred tax assets that are based on estimates of its future results, the prudence and feasibility 
 of possible tax planning strategies, and the economic and political environments in which NewGenIvf does business;                   |

| ● | the outcome of future tax                            
 audits, examinations, or administrative appeals; and |

| ● | limitations or adverse                                               
 findings regarding its ability to do business in some jurisdictions. |

Any of these developments
could have an adverse effect on its results of operations.

NewGenIvf’s reported financial results may be adversely affected by changes in accounting principles generally accepted in the U.S.

A change in the U.S. accounting
principles could have a significant effect on NewGenIvf’s reported results of operations and could affect the reporting of transactions
already completed before the announcement of a change.The adoption of new or revised accounting principles may require it to make changes
to its systems, processes and control, which could have a significant effect on its reported financial results, cause unexpected financial
reporting fluctuations, retroactively affect previously reported results or require it to make costly changes to its operational processes
and accounting systems upon or following the adoption of these standards.

If NewGenIvf’s estimates or judgments relating to its critical accounting policies prove to be incorrect, its results of operations could be adversely affected.

The preparation of financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in
NewGenIvf’s consolidated financial statements and accompanying notes appearing elsewhere in this prospectus. NewGenIvf bases its
estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, as provided
in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of NewGenIvf — Critical Accounting Policies, Judgments and Estimates.” The results of these estimates form the basis for making judgments about the
carrying values of assets, liabilities and